Impact Factor
2.54
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.24
113 total citations
h5-index
13
h5 depth signal
Cited share
55.3%
52 of 94
Total citations
113
Citation footprint
Metric signal
1.47
External metric anchor
Self-citation
0.9%
1 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
190
India
62
Canada
50
China
45
Turkey
43
Citing Fields of Research
Hematology
340
Oncology
185
Palliative Care
60
Lymphomas
56
Musculoskeletal & Nerve Cancer
46
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,165
Articles tracked across the journal lifetime
Indexed publication set
94
52 cited publications
Last 12 months
39
4.9 publications/month
Open access share
12.8%
5 OA publications in the last year
Leading citing country
United States
190 citing publications
Leading citing field
Hematology
340 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v3n1, 1986-
v3n1, 1986-
Active Coverage
Research Focus & Classification
Indexed Subjects
Hematology
Oncology
Palliative Care
Anesthetic & Pain Medicine
Broad Categories
Hematology
Neoplasms
Pediatrics
MeSH Descriptors
Child
Hematologic Diseases
Infant
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1080/08880018.2026.2733752
Open DOI
Factors associated with early death among children and adolescents with cancer in Brazil: a nationwide registry-based study
Childhood cancer is a major global public health challenge, with an estimated 397,000 to 429,000 new cases diagnosed annually among children and adolescents aged 0–19 years.1–3 Although relatively ...
03
DOI 10.1080/08880018.2026.2731104
Open DOI
Infection profile and risk factors for adverse outcomes in children with febrile neutropenia: a single-center study from Northwestern India
Neutropenia can stem from the neoplastic disease itself, antineoplastic therapy, infections, other medications, or a combination of these factors.1 In pediatric oncology, febrile neutropenia (FN) i...
04
05
DOI 10.1080/08880018.2026.2729160
Open DOI
Health-related quality of life in pediatric sickle cell disease: insights from a Portuguese hospital-based study
06
DOI 10.1080/08880018.2026.2721638
Open DOI
Evaluating the Feasibility and Acceptability of Bright IDEAS Problem-Solving Skills Training Among Uganda Professionals Caring for Children with Cancer: A Single-Arm Pilot Study
Psychosocial care is increasingly recognized as an essential component of comprehensive oncology. In low and middle-income countries (LMICs) in particular patients and caregivers face substantial e...
07
08
DOI 10.1080/08880018.2026.2714775
Open DOI
Prevalence of High Tumor Mutational Burden Among Pediatric Patients With Solid Tumors
09
DOI 10.1080/08880018.2026.2703639
Open DOI
Letter to the Editor: Horner Syndrome as a Complication of Neuroblastoma Treatment
Dear Editor,We read with great interest the recent article by Kuchalska et al. entitled “Horner syndrome as a complication of neuroblastoma treatment”.1 The authors should be commended for this com...
10
DOI 10.1080/08880018.2026.2696405
Open DOI
Current Perspective: The Role of Liquid Biopsy in Diagnosis and Management of Pediatric Rhabdomyosarcomas (RMS)
Rhabdomyosarcoma is the third most common extracranial solid tumor of childhood. Despite extensive research over the preceding decades, prognosis in children with metastatic or recurrent disease remains very poor with overall 5-year surv...
Bibliographical & Catalog Notes
Online version has title: Pediatric hematology-oncology.
Title from cover.
Frequency of the online version varies from the print version.
Also issued online.
Vol. 9, no. 1 (JAN-MAR 1992)19920608 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper